Sickle cell disease: Nursing process (ADPIE)

Last updated: January 26, 2022

Sickle cell disease: Nursing process (ADPIE)

Watch later

Watch later

Drug administration and dosing regimens
Hyperbilirubinemia: Nursing process (ADPIE)
Sickle cell disease: Nursing process (ADPIE)
Antibiotics - Aminoglycosides: Nursing pharmacology
Antiarrhythmics: Nursing pharmacology
Immunosuppressants for autoimmune diseases: Nursing pharmacology
Celiac disease: Nursing process (ADPIE)
Irritable bowel syndrome (IBS): Nursing
Somatosensory pathways
Pericarditis: Nursing
Pharmacokinetics - Elimination: Nursing pharmacology
Anatomy clinical correlates: Glossopharyngeal (CN IX), vagus (X), spinal accessory (CN XI) and hypoglossal (CN XII) nerves
MEN syndromes: Clinical
Anatomy clinical correlates: Vertebral canal
Anatomy clinical correlates: Spinal cord pathways
Anatomy clinical correlates: Posterior blood supply to the brain
Abdominal pain: Clinical
Gastrointestinal bleeding: Clinical
Local anesthetics
Migraine medications
Nonbenzodiazepine anticonvulsants
Stroke: Clinical
Gastrointestinal system anatomy and physiology
Glucocorticoids
Typical antipsychotics
Non-corticosteroid immunosuppressants and immunotherapies
Pyramidal and extrapyramidal tracts
Cholinomimetics: Direct agonists
Atypical antipsychotics
Action potentials in myocytes
Action potentials in pacemaker cells
Excitability and refractory periods
Cardiac excitation-contraction coupling
ACE inhibitors, ARBs and direct renin inhibitors
Muscle weakness: Clinical
Hyperthyroidism medications
Oxygen binding capacity and oxygen content
Hypocalcemia
Resting membrane potential
Opioid agonists, mixed agonist-antagonists and partial agonists
Hyperplasia and hypertrophy
Leukodystrophy
Complement system
Hypothyroidism medications
Regulation of renal blood flow
Distal convoluted tubule
Sodium homeostasis
Insulin
Parathyroid hormone
Chronic bronchitis
Pulmonary corticosteroids and mast cell inhibitors
Seronegative arthritis: Clinical
Blood transfusion reactions and transplant rejection: Pathology review
Hunger and satiety
Emphysema
Normal heart sounds
Nervous system anatomy and physiology
Insulins
Pigmentation skin disorders: Pathology review
Anatomy of the inferior mediastinum
Osteoporosis
Approach to pneumoperitoneum and peritonitis (perforated viscus): Clinical sciences
Bacteroides fragilis
Shigella
Diabetes mellitus: Pathology review
Hematopoietic medications
Non-biologic disease modifying anti-rheumatic drugs (DMARDs)
Class IV antiarrhythmics: Calcium channel blockers and others
Amyloidosis
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
Cytokines
Gallstone ileus
Dementia: Pathology review
Appendicitis: Pathology review
Complement deficiency
Cholesterol metabolism
Adrenergic antagonists: Alpha blockers
Class I antiarrhythmics: Sodium channel blockers
Anatomy clinical correlates: Other abdominal organs
Anatomy of the breast
Atrial fibrillation
Factor V Leiden
Iron deficiency anemia
Sickle cell disease (NORD)
Seizures: Pathology review
Respiratory system anatomy and physiology
Pulmonary edema
Developmental and learning disorders: Pathology review
Anatomy and physiology of the male reproductive system
Prostate cancer
Arterial disease

Notes

SICKLE CELL ANEMIA

KEY POINTS
NOTES
PATIENT REPORT
  • 24-year-old man
  • History sickle cell anemia
  • Sudden, severe pain in back, hands, and feet

PATHOPHYSIOLOGY
  • Sickle cell disease
    • Group of genetic conditions affecting hemoglobin that cause red blood cells to sickle
    • Cells become more fragile and are easily destroyed 
    • Sickled cells are less flexible and can occlude vessels leading to ischemia and necrosis
  • Red blood cells carry oxygen and contain hemoglobin A
  • Hemoglobin A contains two α-globin and two β-globin chains making them flexible
  • Causes
    • Mutation in HBB gene
  • Risk factors
    • Ancestors from sub-Saharan Africa, South America, Caribbean, and Central America
    • Mediterranean, Middle Eastern, Indian, and Asian descent 
  • Signs and symptoms
    • Fatigue
    • Pallor
    • Bone or joint pain
    • Swelling
    • Headaches
  • Complications
    • Avascular necrosis
    • Seizures
    • Stroke
    • Acute chest syndrome
    • Sickle cell nephropahy
    • Splenic infarct
    • Infection
    • Vision loss 

DIAGNOSIS AND TREATMENT
  • Diagnosis
    • DNA testing 
    • Routine newborn screening
  • Treatment
    • Oxygen
    • Fluids
    • Folic acid
    • Analgesics
    • Antibiotics 
    • Hydroxyurea
    • Vaccination

ASSESSMENT
  • Tired
  • Temperature: 101.1 F (38.3 C)
  • Heart rate: 110
  • Respiratory rate: 20
  • Clear breath sounds
  • Blood pressure: 112/78 mmHg
  • Oxygen saturation: 91% room air
  • Pain: 9/10
  • IV fluids infusing
  • 1+ edema to hands
  • Skin turgor decreased
  • Dry mucous membranes
  • Folic acid and hydroxyurea at home
  • Hemoglobin: 10.9 mg/dL (6.76 mmol/L)
  • Hematocrit: 38%
  • Red blood cells: 4.0 million/mm3 (4.0 x 1012/L)
  • White blood cells: 18,000/mm3 (18 x 109/L)
  • Reticulocytes: 12%

NURSING DIAGNOSES
  • Impaired gas exchange related to decreased oxygen-carrying capacity
  • Ineffective peripheral tissue perfusion related to decreased oxygen-carrying capacity
  • Acute pain related to intravascular sickling 
  • Deficient fluid volume related to infection, fever, nausea, and vomiting

PLANNING
  • Increase oxygen saturation
  • Adequate perfusion and oxygenation to peripheral tissues
  • Manage pain
  • Adequate fluid balance
  • Resolve infection
  • Normalize temperature
  • Free of nausea and vomiting

IMPLEMENTATION
  • Administer medications as prescribed
  • Apply warm compresses
  • Demonstrate incentive spirometer
  • Titrate oxygen as needed
  • Remind how to prevent exacerbations

EVALUATION
  • Temperature: 99.8 F (37.7 C)
  • Heart rate: 86
  • Respiratory rate: 16
  • Clear breath sounds
  • Blood pressure: 118/78 mmHg
  • Oxygen saturation: 96% 4L nasal cannula
  • Pain: 7/10
  • Increase analgesic, reapply warm compresses

Transcript

Watch video only

Darnell Tyler is a 24-year-old Black male client with a history of sickle cell disease who presents to the emergency department, or ED, with a report of sudden, severe pain, rated a 9/10 that started late last night in his back, hands and feet.

He says he has been nauseous and vomiting for the last few days. After blood is drawn for culture, IV fluids and antibiotics are started. Then Darnell is admitted to the medical unit for further treatment and evaluation.

Sickle cell disease is a group of genetic conditions that affect hemoglobin, which can cause red blood cells to take the shape of a sickle or crescent. As a result, these red blood cells are more fragile and can be destroyed more easily, which can cause anemia.

Normally, red blood cells are able to carry oxygen from the lungs to peripheral tissues because they contain hemoglobin A, or HbA for short. Now, hemoglobin A is made up of two α-globin and two β-globin peptide chains, giving red blood cells a characteristic flexible biconcave shape that allows them to travel easily through blood vessels.

With this in mind, sickle cell disease is caused by a mutation in the HBB gene, which almost always results in the 6th amino acid of beta globin being a valine instead of glutamic acid.

As a result, two normal α-globin and two mutated β-globin peptide chains give rise to an abnormal hemoglobin called hemoglobin S for sickle, or HbS for short.

Now, under normal conditions, HbS is also able to carry oxygen quite well. However, under conditions such as hypoxia, acidosis, or dehydration, HbS forms long chains within the red blood cells.

This ultimately distorts the red blood cells into a rigid and fragile crescent shape that looks like a sickle. Now, sickle cell disease is autosomal recessive, so both parents must pass the mutated HBB gene to their child, so they will be homozygous for HbS.

This is especially common in individuals whose ancestors came from Sub-Saharan Africa, as well as South America, the Caribbean, and Central America. The mutated gene is also quite common among individuals of Mediterranean, Middle Eastern, Indian, and Asian descent.

On the other hand, if a client has one mutated HBB gene and one normal HBB gene, then they’re heterozygous for HbS, which makes them sickle cell carriers, also called sickle trait.

These clients usually have no health problems unless they are exposed to extreme conditions like dehydration or high altitude.Now, some of these fragile sickle cells get prematurely destroyed in blood vessels, a process often referred to as intravascular hemolysis; while others get destroyed by the spleen, which is also known as extravascular hemolysis.

Increased red blood cell breakdown leads to anemia and symptoms such as fatigue, pallor, shortness of breath, and jaundice. Less red blood cells stimulate bone marrow erythropoiesis, leading to new bone formation, and extramedullary hematopoiesis leading to hepatomegaly.

Finally, sickle cells can't travel easily through blood vessels, so they may get stuck and clump together in smaller blood vessels, causing vaso-occlusion, meaning they block the blood flow, eventually leading to tissue ischemia and pain, as well as infarction and necrosis.

This is especially common in the long bones and the back, as well as hands, and feet. So these clients typically present with bone or joint pain without a history of trauma, as well as swelling and pain in the fingers and toes.

Vaso-occlusion can result in many complications, which is known as a vaso-occlusive or sickle cell crisis. An important complication is avascular necrosis of the hips, which can cause tiny breaks in the bone and eventually, the bone may collapse.

In the brain, vaso-occlusion can lead to headaches, seizures, and even ischemic stroke. Vaso-occlusion in the lungs and cause a pulmonary infarction, which is often referred to as acute chest syndrome, and may present with chest pain, dyspnea, and cough.

Another important complication in the lungs is pulmonary hypertension, which can even lead to cor pulmonale, often referred to as right-side heart failure. In the kidneys, vaso-occlusion can cause sickle cell nephropathy, which is associated with hematuria and proteinuria; as well as chronic kidney disease.

Next, red blood cells can clog up the spleen and cause splenic infarcts; and since the spleen plays an important role in immunity against encapsulated bacteria, a client with sickle cell disease will be susceptible to infections by encapsulated bacteria, including Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae.

Finally, clogging of small blood vessels of the retina can lead to retinopathy and vision loss. To prevent these complications, it’s important to diagnose sickle cell disease as early as possible.

Diagnosis of sickle cell disease can be done prenatally with DNA testing, as well as with routine newborn screening. Hemoglobin electrophoresis can be performed to identify HbS.

Another important diagnostic study is a peripheral blood smear, which shows the characteristic sickle cells. Additionally, since there’s hemolysis, the blood levels of unconjugated bilirubin are often increased, while the hemoglobin levels are decreased.

To compensate, the bone marrow revs up and starts pumping out immature red blood cells called reticulocytes, therefore the reticulocyte count is usually elevated. In clients with bacterial infection, white blood cell count can also rise.